
Opinion|Videos|March 21, 2025
Integrating Bispecific Antibodies in Community Oncology: Benefits and Considerations
Experts discuss the benefits of implementing and operationalizing bispecifics in the community oncology setting.
Advertisement
Episodes in this series

Video content above is prompted by the following:
What are the benefits of implementing/operationalizing bispecifics in the community oncology setting?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled
2
Experts, Patients Highlight Barriers to Arthritis Care Amid World Arthritis Day Observance
3
FDA Expands Upadacitinib Label for Treating Inflammatory Bowel Disease
4
Medical School Diversity Declines Following Affirmative Action Repeal
5